Drug
Fosamprenavir clinical trials
Also written Lexiva, GW433908 and TELZIR.
- studies test it
- 27
- open now
- 2
- in phase 3
- 9
- first study started
- 2000
Keep track of what changes. Save the fosamprenavir studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Development codes
Studies by the year they started
26 studies that test it; most in 2005 (5); 1 more planned to start later
| Year | Studies |
|---|---|
| 2000 | 2 |
| 2001 | 2 |
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 2 |
| 2005 | 5 |
| 2007 | 1 |
| 2008 | 5 |
| 2009 | 2 |
| 2010 | 2 |
| 2011 | 2 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 9
- Phase 2
- 4
- Phase 3
- 9
- Phase 4
- 3
- No phase
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 15 · Other 12
ViiV Healthcare (7) · GlaxoSmithKline (5) · Garden State Infectious Disease Associates, PA (3) · Radboud University Medical Center (2) · Medical College of Wisconsin (2) · Glaxo Wellcome (2) · French National Agency for Research on AIDS and Viral Hepatitis (1) · Germans Trias i Pujol Hospital (1)
Often tested with
Tested in the same studies.
Ritonavir (19) · Nelfinavir (3) · Lopinavir-ritonavir drug combination (3) · Maraviroc (3) · Saquinavir (2) · Indinavir (2) · Darunavir/Ritonavir (2) · Raltegravir (2)
Studies
Open first, then newest update. How each study uses fosamprenavir is read from its arms, and is right about nine times in ten.
Testing it · 27
- Oral Fosamprenavir for GERDNot yet recruitingPhase 2Medical College of WisconsinNCT06704100Written as Fosamprenavir Calcium 700 MG Oral Tablet
- Fosamprenavir for Laryngopharyngeal Upper Airway Tissue Treatment and Enzyme ReductionRecruitingPhase 2Medical College of WisconsinNCT04383262Written as Fosamprenavir Calcium
- Dual Boosted Protease Inhibitor Regimens Without Any Additional Antiretroviral Therapy in HIV-1 Infected Patients (ANRS127)CompletedPhase 2French National Agency for Research on AIDS and Viral HepatitisNCT00122603Written as Fosamprenavir
- Interaction Between Fosamprenavir/Ritonavir and a Single-dose Olanzapine (FORZA)CompletedPhase 1Radboud University Medical CenterNCT00977301Written as fosamprenavir/ritonavir
- Pharmacokinetic Study of Posaconazole Boosted FosamprenavirCompletedPhase 1Radboud University Medical CenterNCT00817765Written as Fosamprenavir
- Study to Determine the Pharmacokinetic Behavior of Antiretroviral Drugs in Patients Infected by HIVCompletedPhase 1Germans Trias i Pujol HospitalNCT00307502Written as Fos-amprenavir/ritonavir
- Fosamprenavir Versus Other Protease InhibitorsCompletedPhase 3ViiV HealthcareNCT00094523Written as Fosamprenavir
- GSK1349572 Drug Interaction Study With Fosamprenavir/RitonavirCompletedPhase 1ViiV HealthcareNCT01209065Written as Fosamprenavir
- Fosamprenavir Expanded AccessCompletedPhase 4ViiV HealthcareNCT00240552Written as fosamprenavir
- An Interaction Study to Assess Drug Levels in Fasting Healthy Adult SubjectsCompletedNot applicableGarden State Infectious Disease Associates, PANCT00802074Written as Fosamprenavir
- An Interaction Study to Assess Drug Levels in Healthy Adult SubjectsCompletedNot applicableGarden State Infectious Disease Associates, PANCT00614991Written as Fosamprenavir
- An Interaction Study to Assess Drug Levels in Healthy Adult SubjectsCompletedPhase 2Garden State Infectious Disease Associates, PANCT00764465Written as Fosamprenavir
- HCV Evolution in HIV/HCV (Genotype 1) Coinfected Patients Treated With FosamprenavirCompletedPhase 4Fundacion SEIMC-GESIDANCT01222611Written as Fosamprenavir
- Interaction of Buprenorphine With HIV Medications and Tuberculosis MedicationsCompletedPhase 1University of California, San FranciscoNCT00877591Written as Fosamprenavir/Ritonavir
- A Pharmacokinetic (PK) Study of a Combination of Indinavir, Ritonavir, and AmprenavirCompletedPhase 4Emory UniversityNCT00148785Written as Indinavir/Ritonavir/Fosamprenavir
- A Study To Assess GW433908 (Fosamprenavir) Containing Regimens In HIV-1 Infected SubjectsCompletedPhase 3ViiV HealthcareNCT00296504Written as fosamprenavir (GW433908)
- Study to Explore Safety And Tolerability of Fosamprenavir With or Without Ritonavir in Combination With TRIZIVIR or COMBIVIRCompletedPhase 3GlaxoSmithKlineNCT00043888Written as fosamprenavir
- HIV-1 Infection Study of Once a Day Versus Twice a Day Protease Inhibitor in Antiretroviral Treatment Naive AdultsCompletedPhase 3ViiV HealthcareNCT00450580Written as fosamprenavir/ritonavir
- Pharmacokinetic Interaction Between Maraviroc And Fosamprenavir/Ritonavir In Healthy SubjectsCompletedPhase 1ViiV HealthcareNCT01290211Written as Fosamprenavir/ritonavir
- KALETRA Or LEXIVA With Ritonavir Combined With EPIVIR And Abacavir In Naive Subjects Over 48 WeeksCompletedPhase 3GlaxoSmithKlineNCT00085943Written as LEXIVA (GW433908)
See all 27 studies that test fosamprenavir →
Given in every arm · 4 — fosamprenavir is usual care beside what is tested
- Study Of An Investigational Regimen Including FDA Approved HIV Drugs In HIV-Infected Pediatric SubjectsCompletedPhase 2ViiV HealthcareNCT00071760Written as GW433908
- 48-Week Study Of GW433908 And Ritonavir Or GW433908 Alone, Twice Daily In Pediatric Patients With HIV InfectionCompletedPhase 2ViiV HealthcareNCT00089583Written as LEXIVA (GW433908)
- A Clinical Study Of An Investigational Regimen Including Marketed HIV Drugs In HIV-1 Pediatric Subjects Ages 2-18 YearsCompletedPhase 2ViiV HealthcareNCT00040664Written as fosamprenavir
- Boosted Lexiva With Lovaza Adjunctive Therapy in Hypertriglyceridemic, HIV-Infected SubjectsCompletedPhase 4Felizarta, Franco, M.D.NCT01010399Written as fosamprenavir/ritonavir
As the comparator · 1 — what is tested is compared with fosamprenavir
Codes
What other systems call fosamprenavir · ClinicalTrials.gg INT004343
- MeSH (NLM) C426859fosamprenavirConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) WOU1621EEGFOSAMPRENAVIRConfirmed FDA, NLM, Wikidata
- RxNorm 358262Confirmed FDA, Wikidata
- Wikidata Q1385311fosamprenavirConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C83720FosamprenavirOne source FDA
- DrugBank DB01319One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C426859 | fosamprenavir | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | WOU1621EEG | FOSAMPRENAVIR | Confirmed FDA, NLM, Wikidata |
| RxNorm | 358262 | — | Confirmed FDA, Wikidata |
| Wikidata | Q1385311 | fosamprenavir | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C83720 | Fosamprenavir | One source FDA |
| DrugBank | DB01319 | — | One source Wikidata |
Also registered as fosamprenavir calcium (UNII ID1GU2627N · RxNorm 402365) and fosamprenavir sodium (UNII XSG28FSA0W).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.